Wednesday, 18 Oct 2017

PsA/SpA

Date Typesort ascending Title Save
27 Jul 2015 Social Having cholecystectomy-confirmed gallstones was assoc w/ risk of psoriasis (RR 2·20) & concomitant PsA (RR 4·41) http://t.co/xW9BuiTQHR
08 Jun 2016 Social Secukinumab data presented at EULAR; Novartis plans H2H trial of Cosentyx & Humira; details to follow https://t.co/zjA8Rgw0cX
14 Jul 2016 Social in 428 SpA pts, BMI (obesity) has no effect on ASDAS. BMI weakly correlates w/ CRP, other PRO's. https://t.co/FcTfEicYpN
18 Jul 2017 Social 320 pt Rheum-Derm clinic in Vancouver - lupus is most common rheum dx; dermatitis & psoriasis most common Derm Dx https://t.co/soA3UXsfXF
15 Sep 2016 Social RT @RonanTKavanagh: patients with psoriatic spondyloarthritis more steroid responsive than patients with Ank Spond (60% vs 20% at week 2. #…
11 Nov 2015 Social Dr Atul Deodhar on video at RheumNow, discussing new therapies for ankylosing splondylitis. Live from #ACR15 https://t.co/wJFcAurQYE
29 Sep 2017 Social Higher MASEI (enthesitis) scores in PsA assoc w/ more Jt damage, ankylosis, arthritis mutilans periostitis, axial Dz https://t.co/NKw37wkka5
17 Feb 2017 Social RT @DrRachelTate: Tofa as an option for AS? No FDA indication but a potential off label option. E. Ruderman MD #rwcs2017 @RWCSmtg @RheumNow…
23 Oct 2016 Social Dr. Sergio Schwartzman comments on new Ocular Screening Guidlines for Hydroxychloroquine at RheumNow https://t.co/Qm1iDM77Jo
16 Oct 2017 Social Population survey found psoriasis/PsA in 1.4-3.3%; Nearly 1/2 not seeing MD or stopped biologic for safety/no effect https://t.co/JGHWuIUacK
08 Feb 2016 Social Acute sacroiliitis Dx by bone or CT scan. Causes include pyogenic infx, brucellosis, crystal induced, neoplasia https://t.co/toLl8suM0i
02 Jul 2015 Social Ixekizumab (anti-IL17) is superior to Enbrel in 1224 pts w/ plaque psoriasis (UNCOVER-2) w/ rapid decr in itch scores http://t.co/ozZbHEq6Wu
28 Mar 2017 Social RT @CBSHealth: FDA approves powerful new drug for eczema -- but it comes with a hefty price tag https://t.co/EOjOgCdoci https://t.co/V49wgh…
04 Jan 2017 Social NICE recommends apremilast for use in psoriatic arthritis w/in UK NHS. Risk of suidical ideation is 0.2% (3/1441) https://t.co/ZFDSo3B81u
21 Jan 2017 Social What you need to know about management of axial SpA:the 2016 update of the ASAS-EULAR recommendations @DrPetryna https://t.co/E4YSqbBG83
02 May 2016 Social Health Canada approves secukinumab for use in psoriatic arthritis and anklylosing spondylitis https://t.co/TmmJyBXf24
12 May 2015 Social Reveille writes no biomarker has reproducibly shown to assess Dz activity or predict outcome; remains an unmet need http://t.co/jTZDCluiky
07 Dec 2015 Social Metformin decreases TH17 cells & IL-22; new study shows it also transforms microbiome in Type 2 diabetes https://t.co/13FFmvKjeQ
17 Nov 2016 Social RT @HealioRheum: Guselkumab found safe and effective for treatment of psoriatic arthritis https://t.co/fcjn3Rcdcd #ACR16
18 Feb 2016 Social IL-36 is an important mediator of bowel inflammation in mouse model of IBD, Blocking IL-36 improves the IBD https://t.co/Cr3bSsDIJk